Companies: 10,795·Total market cap: $144.5T
Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.

PTHSAMEXHealthcare● Active
$26.62
+$1.07(+4.19%)
Market Cap$17263097
P/E Ratio—
52W High$54.29
52W Low$10.6
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Pelthos Therapeutics Inc. (PTHS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · PTHS · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-40.69pths eps ttm · pths earnings per shareEarnings history
PE Ratio (TTM)—pths pe ratio ttm · pths price to earningsPE Ratio deep dive
Revenue (TTM)$27.7Mpths revenue ttm · pths annual revenueFull revenue history
Dividend YieldNo Dividenddoes pths pay dividends · pths dividend yieldDividend history
Shares Outstanding1.9Mpths shares outstanding · pths floatShares outstanding history
Next EarningsAug 12, 2026Est.pths earnings date · pths next earningsEarnings history

Explore Pelthos Therapeutics Inc. Data

pths stock data · financials
Market Cap$17.3Mpths market cap · pths valuation
Analyst Forecast$61 · Buy
DividendsNo Dividenddoes pelthos therapeutics inc. pay dividends · pths dividend yield
Revenue$16.8Mpelthos therapeutics inc. annual revenue · pths revenue
EarningsEPS $-23.04-70.16%pths earnings · pths eps
PE Ratio—pths pe ratio · pths price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$16.8M
202320242025
pelthos therapeutics inc. revenue · pths revenue 2025
FY 2025Net Income-$43.3M▼ 444.53% YoY
202320242025
pelthos therapeutics inc. net income · pths profit 2025
FY 2025EPS$-23.04▼ 70.16% YoY
202320242025
pths eps · pelthos therapeutics inc. earnings per share 2025
TTM:Revenue: $27.7MNet Income: -$51.6MEPS: $-40.69View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy3 analystsis pths a buy · pths analyst rating
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$55.00Low
$26.62Current
$60.50Avg Target127.27% upside
$66.00High
pths price target · pths 12 month forecast

Total: 3 · Buy rate: 100.0%

The PTHS analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $60.50, representing +127.27% upside from the current price of $26.62.

Stock Performance

Full History
1D+4.19%
1W+1.37%
1M+4.39%
3M+15.49%
YTD-14.13%
1Y+125.59%
5Y+125.59%

About Pelthos Therapeutics Inc.

CEOScott Plesha
IPO DateJul 2, 2025
Employees4
CountryUS
Websitepelthos.com

Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primar…

BiotechnologyHealthcareAMEXUS

what is pelthos therapeutics inc. · pths stock overview · pelthos therapeutics inc. company profile · who is pelthos therapeutics inc. ceo · pths AMEX · pelthos therapeutics inc. headquarters · pelthos therapeutics inc. business segments

About Stock Overview & Key Data

Pelthos Therapeutics Inc. (PTHS) is a Healthcare company in the Biotechnology industry, listed on AMEX since Jul 2, 2025. As of the latest trading session, PTHS stock price is $26.62, with a market capitalization of $17.3M. The stock has returned +125.59% over the past 12 months and -14.13% year-to-date.

According to 3 Wall Street analysts, the consensus rating for Pelthos Therapeutics Inc. stock is Buy, with an average 12-month price target of $60.50. In fiscal year 2025, Pelthos Therapeutics Inc. reported revenue of $16.8M and net income of -$43.3M. For detailed data — including Pelthos Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Pelthos Therapeutics Inc. (PTHS) stock price is $26.62. The stock is traded on AMEX under the ticker symbol PTHS. The 52-week range is $10.60 – $54.29.

PTHS stock pricePTHS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice